Загрузка...
Quality of life and long term therapy in patients with chronic myeloid leukemia
Since the development of imatinib and other tyrosine kinase inhibitors (TKIs), the prognosis for patients with chronic myeloid leukemia (CML) has markedly improved, such that most patients diagnosed with CML can now expect to live with their disease rather than die from it. However, most patients wi...
Сохранить в:
| Опубликовано в: : | Curr Hematol Malig Rep |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4860261/ https://ncbi.nlm.nih.gov/pubmed/26879546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-016-0306-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|